Legend:
CC = Baltimore Convention Center,
H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
|
386 * !
|
Tue, 8/1/2017,
2:00 PM -
3:50 PM
|
CC-341
|
Estimands: What Is Essential Is Invisible to the Eye — Invited Papers
|
Biopharmaceutical Section , ENAR , Biometrics Section
|
Organizer(s): Mouna Akacha , Novartis Pharma AG
|
Chair(s): Joan Buenconsejo, AstraZeneca
|
2:05 PM
|
A Dialogue on Estimands
—
Stephen J Ruberg, Eli Lilly and Co
|
2:25 PM
|
Defining estimands in pain studies
—
Paul Gallo, Novartis
|
2:45 PM
|
Application of the Tripartite Estimands in a Diabetes Clinical Trial
—
Junxiang Luo, Eli Lilly and Company ; Yongming Qu, Eli Lilly and Company ; Stephen J Ruberg, Eli Lilly and Co
|
3:05 PM
|
Causal Estimands in Randomized Trials
—
Miguel Hernan, Harvard TH Chan School of Public Health
|
3:25 PM
|
Discussant: Gregory Levin, FDA
|
3:45 PM
|
Floor Discussion
|